Peran Inspeksi Diri dalam Menjamin Mutu Distribusi Obat: Studi Kasus pada Beberapa Pedagang Besar Farmasi
DOI:
https://doi.org/10.59841/an-najat.v3i3.2835Keywords:
drug distribution, GDP compliance,, pharmaceutical wholesalers,Abstract
This review explores the role of self-inspection in maintaining the quality of drug distribution, with a specific focus on case studies involving several pharmaceutical wholesalers (Pedagang Besar Farmasi). The objective is to evaluate how self-inspection is implemented, identify common obstacles, and assess its effectiveness in ensuring compliance with Good Distribution Practices (GDP). Through a qualitative analysis of selected literature and documented practices within Indonesian pharmaceutical wholesalers, the study finds that consistent and well-documented self-inspections can significantly improve operational quality, support regulatory compliance, and mitigate distribution risks. However, gaps in personnel competency, irregular inspection schedules, and limited follow-up actions are recurring challenges. The review emphasizes the need for stronger internal audit frameworks, management commitment, and regulatory guidance to optimize the role of self-inspection as a quality assurance tool in pharmaceutical distribution.
References
Annisa, V. (2024). Kajian penerapan Good Manufacturing Practice (GMP) di industri farmasi Indonesia. Jurnal Farmasetika Indonesia, 9(1), 45–56.Aprini, A., & Alfian, S. D. (2022). Evaluasi CDOB aspek transportasi dan metode penjualan pada salah satu PBF di Kabupaten Bekasi. Jurnal Farmasi dan Ilmu Kefarmasian Indonesia, 21(1), 31–40. https://doi.org/10.20473/fiki.V21I1.2022Lintogareng, O. J., Sari, A. D., & Firmansyah, R. (2022). Implementasi CDOB pada Pedagang Besar Farmasi PT Parit Padang Global. Jurnal Medika Pharmacon, 8(2), 101–110. https://doi.org/10.32539/jmp.v8i2.347Putri, M. F. F. D. (2023). Evaluasi penerapan CDOB di PBF Rajawali Nusindo Yogyakarta. Jurnal Kefarmasian Nasional, 11(1), 73–82.Putri, N. Y. P., & Dandan, A. (2023). Evaluasi penerapan CDOB dalam distribusi psikotropika dan OMPF pada salah satu PBF di Kota Tasikmalaya. Jurnal Kesehatan dan Farmasi Indonesia, 14(2), 91–99.Wulandari, M., Rahayu, A., & Andini, F. (2023). Gambaran pelaksanaan CDOB pada PBF PT Kimia Farma Trading Distribution dan PT Enseval Putera Megatrading di Kota Batam. The Journal of Global Health Science Research, 1(2), 20–30.BPOM RI. (2020). Peraturan Kepala Badan Pengawas Obat dan Makanan Republik Indonesia Nomor 6 Tahun 2020 tentang Pedoman Cara Distribusi Obat yang Baik (CDOB). Jakarta: Badan POM RI.WHO. (2022). Good Distribution Practices for pharmaceutical products. Geneva: World Health Organization. Retrieved https://www.who.int/publications/i/item/gdp-guidelines-2022from Aulia, S. R., & Wibowo, A. (2021). Peran audit internal dalam sistem manajemen mutu distribusi farmasi di Indonesia. Jurnal Ilmiah Farmasi, 17(3), 155–163. https://doi.org/10.14710/jif.v17i3.2021.
Rahmawati, N., & Sutrisno, H. (2020). Implementasi CDOB dalam sistem distribusi farmasi: Studi pada PBF skala kecil. Jurnal Farmasi dan Kesehatan Indonesia, 6(2), 89–96.
Suryaningsih, L., & Fauzan, M. A. (2021). Analisis efektivitas inspeksi diri dalam mendukung sistem mutu distribusi. Prosiding Seminar Nasional Farmasi Indonesia, 3(1), 55–62.Maulida, N., & Kurniawan, D. (2019). Evaluasi pelaksanaan CAPA dalam sistem distribusi farmasi. Jurnal Sistem Kesehatan, 14(1), 22–29.Kemenkes RI. (2021). Profil Kesehatan Indonesia Tahun 2020. Jakarta: Kementerian Kesehatan Republik Indonesia.Astuti, R., & Yuniarti, N. (2022). Kesiapan SDM dalam pelaksanaan audit mutu internal di fasilitas distribusi obat. Jurnal Manajemen Farmasi, 12(2), 103–112.Iskandar, A., & Sasmita, L. (2020). Manajemen risiko mutu dalam distribusi sediaan farmasi. Jurnal Ilmu dan Teknologi Farmasi, 25(2), 88–96.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 An-Najat
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
